Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Longeveron Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q2 2024
- Shares held
- 263.8K
- −57.5K (−17.9%) vs. Q2 2024
- Total value
- $512.3K
- −$5.66K (−1.1%) vs. Q2 2024
- New holders
- 7
- 5 more added
- Sold out
- 8
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 128,947 | $250.2K | 0.00% | +97,953+316.0% | Added |
| Vanguard Group Inc | 44,984 | $87.3K | 0.00% | +44,984 | New |
| Capital Investment Advisory Services, LLC | 26,525 | $51.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,180 | $29.4K | 0.00% | +15,180 | New |
| Creative Planning | 11,200 | $21.7K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 10,000 | $19.9K | 0.00% | +10,000 | New |
| BlackRock, Inc. | 10,016 | $19.4K | 0.00% | +10,016 | New |
| Vontobel Holding Ltd. | 10,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $3.88K | 0.00% | +2,000 | New |
| Morgan Stanley | 1,861 | $3.61K | 0.00% | +452+32.1% | Added |
| Naples Money Management LLC | 700 | $1.36K | 0.00% | +600+600.0% | Added |
| UBS Group AG | 617 | $1.20K | 0.00% | +616+61,600.0% | Added |
| EverSource Wealth Advisors, LLC | 481 | $933 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 464 | $900 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 326 | $632 | 0.00% | +325+32,500.0% | Added |
| The PNC Financial Services Group, Inc. | 297 | $576 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 105 | $204 | 0.00% | −1,577−93.8% | Reduced |
| Aspire Private Capital, LLC | 100 | $194 | 0.00% | +100 | New |
| Householder Group Estate & Retirement Specialist, LLC | 10 | $0 | 0.00% | +10 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −146,700−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −46,041−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,485−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,831−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,899−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| LGT Financial Advisors LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |